APA (7th ed.) Citation

Marciante, K. D., Durda, J. P., Heckbert, S. R., Lumley, T., Rice, K., McKnight, B., . . . Psaty, B. M. (2011). Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenetics and genomics, 21(5), 280. https://doi.org/10.1097/FPC.0b013e328343dd7d

Chicago Style (17th ed.) Citation

Marciante, Kristin D., et al. "Cerivastatin, Genetic Variants, and the Risk of Rhabdomyolysis." Pharmacogenetics and Genomics 21, no. 5 (2011): 280. https://doi.org/10.1097/FPC.0b013e328343dd7d.

MLA (9th ed.) Citation

Marciante, Kristin D., et al. "Cerivastatin, Genetic Variants, and the Risk of Rhabdomyolysis." Pharmacogenetics and Genomics, vol. 21, no. 5, 2011, p. 280, https://doi.org/10.1097/FPC.0b013e328343dd7d.